Back to results
US 2010/0249068 A1Published application
Substituted nucleoside and nucleotide analogs
AssigneeAlios BioPharma, Inc.
InventorsLeonid Beigelman, Lawrence Blatt, Guangyi Wang
Life of this patent
Estimating the term…
Abstract
Disclosed herein are nucleotide analogs with protected phosphates, methods of synthesizing nucleotide analogs with protected phosphates and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the nucleotide analogs with protected phosphates.
Claims57
A compound of Formula (II) or a pharmaceutically acceptable salt or a prodrug thereof:
- wherein:
- each is independently a double or single bond;
- A2 is selected from the group consisting of C (carbon), O (oxygen) and S (sulfur);
- B2 is an optionally substituted heterocyclic base or a derivative thereof;
- D2 is selected from the group consisting of C═CH2, CH2, O (oxygen), S (sulfur), CHF, and CF2;
- R19 is selected from the group consisting of hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aralkyl, dialkylaminoalkylene, alkyl-C(═O)—, aryl-C(═O)—, alkoxyalkyl-C(═O)—, aryloxyalkyl-C(═O)—, alkylsulfonyl, arylsulfonyl, aralkylsulfonyl,
- an —O-linked amino acid, diphosphate, triphosphate or derivatives thereof;
- R20 and R21 are independently selected from the group consisting of hydrogen, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl, an optionally substituted C2-6 alkynyl and an optionally substituted C1-6 haloalkyl, provided that at least one of R20 and R21 is not hydrogen;
- or R20 and R21 are taken together to form a group selected from among C3-6 cycloalkyl, C3-6 cycloalkenyl, C3-6 aryl, and a C3-6 heteroaryl;
- R22 and R27 is independently selected from the group consisting of hydrogen, halogen, —NH2, —NHRa2, NRa2Rb2, —ORa2, —SRa2, —CN, —NC, —N3, —NO2, —N(Rc2)—NRa2Rb2, —N(Rc2)—ORa2, —S—SRa2, —C(═O)Ra2, —C(═O)ORa2, —C(═O)NRa2Rb2, —O—C(═O)ORa2, —O—C(═O)NRa2Rb2, —N(Rc2)—C(═O)NRa2Rb2, —S(═O)Ra2, S(═O)2Ra2, —O—S(═O)2NRa2Rb2, —N(Rc2)—S(═O)2NRa2Rb2, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl, an optionally substituted C2-6 alkynyl and an —O-linked amino acid;
- R23, R24 and R25 are independently absent or selected from the group consisting of hydrogen, halogen, —NH2, —NHRa2, NRa2Rb2, —ORa2, —SRa2, —CN, —NC, —N3, —NO2, —N(Rc2)—NRa2Rb2, —N(Rc2)—ORa2, —S—SRa2, —C(═O)Ra2, —C(═O)ORa2, —C(═O)NRa2Rb2, —O—(C═O)Ra2, —O—C(═O)ORa2, —O—C(═O)NRa2Rb2, —N(Rc2)—C(═O)NRa2Rb2, —S(═O)Ra2, S(═O)2Ra2, —O—S (═O)2l NRa2Rb2, —N(Rc2)—S(═O)2NRa2Rb2, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl, an optionally substituted C2-6 alkynyl, an optionally substituted aralkyl and an —O-linked amino acid;
- or R24 and R25 taken together form —O—C(═O)—O—;
- R26 is absent or selected from the group consisting of hydrogen, halogen, —NH2, —NHRa2, NRa2Rb2, —ORa2, —SRa2, —CN, —NC, —N3, —NO2, —N(Rc2)—NRa2Rb2, —N(Rc2)—ORa2, —S—SRa2, —C(═O)Ra2, —C(═O)ORa2, —C(═O)NRa2Rb2, —O—C(═O)ORa2, —O—C(═O)NRa2Rb2, —N(Rc2)—C(═O)NRa2Rb2, —S(═O)Ra2, S(═O)2Ra2, —O—S(═O)2NRa2, Rb2, —N(Rc2)—S(═O)2NRa2Rb2, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl, an optionally substituted C2-6 alkynyl, an optionally substituted haloalkyl, an optionally substituted hydroxyalkyl and an —O-linked amino acid, or when the bond to R25 indicated by is a double bond, then R25 is a C2-6 alkylidene and R26 is absent;
- Ra2, Rb2 and Rc2 are each independently selected from the group consisting of hydrogen, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl and an optionally substituted heteroaryl(C1-6 alkyl);
- R28 is selected from the group consisting of O−, —OH, an optionally substituted aryloxy or aryl-O—,
- alkyl-C(═O)—O—CH2—O—, alkyl-C(═O)—S—CH2CH2—O— and an —N-linked amino acid;
- R29 is selected from the group consisting of O−, −OH, aryloxy or aryl-O—,
- alkyl-C(═O)—O—CH2—O—, alkyl-C(═O)—S—CH2CH2—O— and an —N-linked amino acid;
- each R30 and each R31 are independently —C≡N or an optionally substituted substituent selected from the group consisting of C1-8 organylcarbonyl, C1-8 alkoxycarbonyl and C1-8 organylaminocarbonyl;
- each R32 is hydrogen or an optionally substituted C1-6-alkyl;
- each n is independently 1 or 2;
- and
- if both R28 and R29 are
- each R30, each R31, each R32 and each n can be the same or different.
21 more elements
A compound of Formula (I) or a pharmaceutically acceptable salt or a prodrug thereof:
- wherein:
- A1 is selected from the group consisting of C (carbon), O (oxygen) and S (sulfur);
- B1 is an optionally substituted heterocyclic base or a derivative thereof;
- D1 is selected from the group consisting of C═CH2, CH2, O (oxygen), S (sulfur), CHF, and CF2;
- R1 is selected from the group consisting of hydrogen, an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted aralkyl, dialkylaminoalkylene, alkyl-C(═O)—, aryl-C(═O)—, alkoxyalkyl-C(═O)—, aryloxyalkyl-C(═O)—, alkylsulfonyl, arylsulfonyl, aralkylsulfonyl,
- an —O-linked amino acid, diphosphate, triphosphate or derivatives thereof;
- R2 and R3 are each independently selected from the group consisting of hydrogen, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl, an optionally substituted C2-6 alkynyl and an optionally substituted C1-6 haloalkyl, provided that at least one of R2 and R3 is not hydrogen;
- or R2 and R3 are taken together to form a group selected from among C3-6 cycloalkyl, C3-6 cycloalkenyl, C3-6 aryl, and a C3-6heteroaryl;
- R4, R7 and R9 is independently selected from the group consisting of hydrogen, halogen, —NH2, —NHRa1, NRa1Rb1, —ORa1, —SRa1, —CN, —NC, —N3, —NO2, —N(Rc1)—NRa1Rb1, —N(Rc1)—ORa1, —S—SRa1, —C(═O)Ra1, —C(═O)ORa1, —C(═O)NRa1Rb1, —O—(C═O)Ra1, —O—C(═O)ORa1, —O—C(═O)NRa1Rb1, —N(Rc1)—C(═O)NRa1Rb1, —S(═O)Ra1, S(═O)2Ra1, —O—S(═O)2NRa1Rb1, —N(Rc1)—S(═O)2NRa1Rb1, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl, an optionally substituted C2-6 alkynyl, an optionally substituted aralkyl and an —O-linked amino acid;
- R5 and R6 is independently absent or selected from the group consisting of hydrogen, halogen, —NH2, —NHRa1, NRa1Rb1, —ORa1, —SRa1, —CN, —NC, —N3, —NO2, —N(Rc1)—NRa1Rb1, —N(Rc1)—ORa1, —S—SRa1, —C(═O)Ra1, —C(═O)ORa1, —C(═O)NRa1Rb1, —O—C(═O)ORa1, —O—C(═O)NRa1Rb1, —N(Rc1)—C(═O)NRa1Rb1, —S(═O)Ra1, S(═O)2Ra1, —O—S(═O)2NRa1Rb1, —N(Rc1)—S(═O)2NRa1Rb1, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl, an optionally substituted C2-6 alkynyl and an —O-linked amino acid;
- or R6 and R7 taken together form —O—C(═O)—O—;
- R8 is halogen, —ORa1, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl, an optionally substituted C2-6 alkynyl and an optionally substituted C1-6 haloalkyl;
- Ra1, Rb1 and Rc1 are each independently selected from the group consisting of hydrogen, an optionally substituted alkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aralkyl and an optionally substituted heteroaryl(C1-6 alkyl);
- R10 is selected from the group consisting of O−, −OH, an optionally substituted aryloxy or aryl-O—,
- alkyl-C(═O)—O—CH2—O—, alkyl-C(═O)—S—CH2CH2—O— and an —N-linked amino acid;
- R11 is selected from the group consisting of O−, −OH, aryloxy or aryl-O—,
- alkyl-C(═O)—O—CH2—O—, alkyl-C(═O)—S—CH2CH2—O— and an —N-linked amino acid;
- each R12 and each R13 are independently —C≡N or an optionally substituted substituent selected from the group consisting of C1-8 organylcarbonyl, C1-8 alkoxycarbonyl and C1-8 organylaminocarbonyl;
- each R14 is hydrogen or an optionally substituted C1-6-alkyl;
- and
- each m is independently 1 or 2;
- and if both R10 and R11 are
- each R12, each R13, each R14 and each m can be the same or different.
20 more elements
Dependencies are inferred from the claim text.